. . . . . . . . . . . . "[N-Acetyltransferase (NAT2) slow acetylation genotype and glutathione S-transferase T1 (GSTT1) null genotype seem to elevate the baseline level of CAs and SCEs and CAs, respectively--possibly because of reduced capacity to detoxify some wide-spread or endogenous genotoxins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:33:42+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .